Drawing for HEMOLINK THE OXYGEN CARRIER

USPTO serial 76173393

HEMOLINK THE OXYGEN CARRIER

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
CHARLON, BARNEY
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HEMOLINK THE OXYGEN CARRIER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Gary D Krugman

GARY D KRUGMAN SUGHRUE MION PLCC2100 PENNSYLVANIA AVE NWWASHINGTON, DC 20037-3202UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Oxygen transporting fluids for administration to living bodies, namely blood substitutes for humansACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 16, 2003ABN1ABANDONMENT - EXPRESS MAILED—
Oct 29, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 29, 2002MAILPAPER RECEIVED—
Oct 15, 2002CNSIINQUIRY AS TO SUSPENSION MAILED—
Mar 4, 2002CNSLLETTER OF SUSPENSION MAILED—
Mar 1, 2002UNPRUNRESPONSIVE/DUPLICATE PAPER RECEIVED—
Nov 14, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 21, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 20, 2001DOCKASSIGNED TO EXAMINER—
Mar 29, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance